| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.093 | 0.01 |
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.089 | 0.02 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.02 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.02 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.086 | 0.02 |
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | 0.084 | 0.02 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.02 |